Predicted dolutegravir resistance in people living with HIV in South Africa during 2020–35: a modelling study
US National Institutes of Health National Institute of Allergy and Infectious Diseases, Swiss National Science Foundation, and University of Zurich Research Priority Program Evolution in Action.
Authors
- Linda Wittkop (ORCID: https://orcid.org/0000-0003-2403-0960)
- Gary Maartens (ORCID: https://orcid.org/0000-0003-3080-6606)
- Jörg Janne Vehreschild (ORCID: https://orcid.org/0000-0002-5446-7170)
- Ard van Sighem (ORCID: https://orcid.org/0000-0002-6656-0516)
- Leigh F. Johnson (ORCID: https://orcid.org/0000-0002-2717-011X)
- Huldrych F. Günthard (ORCID: https://orcid.org/0000-0002-1142-6723)
- Richard Lessells (ORCID: https://orcid.org/0000-0003-0926-710X)
- M. John Gill (ORCID: https://orcid.org/0000-0002-8546-8790)
- Roger D. Kouyos (ORCID: https://orcid.org/0000-0002-9220-8348)
- Francesca Ceccherini‐Silberstein (ORCID: https://orcid.org/0000-0002-6024-5101)
- Tom Loosli (ORCID: https://orcid.org/0000-0003-2049-3562)
- Matthias Egger (ORCID: https://orcid.org/0000-0001-7462-5132)
- Suzanne M Ingle (ORCID: https://orcid.org/0000-0003-3057-6636)
- Anthony Hauser (ORCID: https://orcid.org/0000-0002-7221-1929)
- Caroline Anne Sabin (ORCID: https://orcid.org/0000-0001-5173-2760)
- Johannes Josi
- Nuri Han (ORCID: https://orcid.org/0000-0001-6279-5150)
Institutions
- University of Rome Tor Vergata (IT)
- University of Cape Town (ZA)
- University of Bristol (GB)
- Stichting HIV Monitoring (NL)
- Centre universitaire de médecine générale et santé publique, Lausanne (CH)
- University College London (GB)
Publication Details
- Journal
- The Lancet Global Health
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1016/s2214-109x(24)00553-9
- Citations
- 22
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 30.72
Funders
- National Science Foundation
- Bill and Melinda Gates Foundation
- Pfizer
- Styrelsen för Internationellt Utvecklingssamarbete
- Gilead Sciences
- Deutsches Zentrum für Infektionsforschung
- ViiV Healthcare
- British HIV Association
- University of Bristol
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Bundesministerium für Bildung und Forschung
- Ministerie van Volksgezondheid, Welzijn en Sport
- Bundesministerium für Gesundheit
- Ministero della Salute
- Istituto Superiore di Sanità
- NordForsk
- Astellas Pharma
- Rigshospitalet
- Shionogi
- Universität Zürich
- Università degli Studi di Roma Tor Vergata
- Deutschen Konsortium für Translationale Krebsforschung
- National Institutes of Health
- HORIZON EUROPE Framework Programme
- Medical Research Council
- National Institute on Alcohol Abuse and Alcoholism
- National Institute of Allergy and Infectious Diseases